Heterogeneous, longitudinally stable molecular signatures in response to interferon-beta.
about
Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosisGene regulatory and clinical effects of interferon β in patients with metastatic melanoma: a phase II trialThe role of cell type-specific responses in IFN-β therapy of multiple sclerosis.Janus-like effects of type I interferon in autoimmune diseases.Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunityImmunogenic effects of recombinant interferon-beta therapy disrupt the JAK/STAT pathway in primary immune cells from patients with multiple sclerosis.
P2860
Heterogeneous, longitudinally stable molecular signatures in response to interferon-beta.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Heterogeneous, longitudinally stable molecular signatures in response to interferon-beta.
@ast
Heterogeneous, longitudinally stable molecular signatures in response to interferon-beta.
@en
type
label
Heterogeneous, longitudinally stable molecular signatures in response to interferon-beta.
@ast
Heterogeneous, longitudinally stable molecular signatures in response to interferon-beta.
@en
prefLabel
Heterogeneous, longitudinally stable molecular signatures in response to interferon-beta.
@ast
Heterogeneous, longitudinally stable molecular signatures in response to interferon-beta.
@en
P2093
P2860
P1476
Heterogeneous, longitudinally stable molecular signatures in response to interferon-beta.
@en
P2093
Anupama Josyula
Jar-Chi Lee
Jennifer Shrock
Joerg Schlaak
M R Sandhya Rani
Richard A Rudick
Richard M Ransohoff
Swathi Chakraborthy
P2860
P356
10.1111/J.1749-6632.2009.05068.X
P407
P50
P577
2009-12-01T00:00:00Z